Ryvu Therapeutics SA
WSE:RVU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
|
I
|
InternetArray Inc
OTC:INAR
|
US |
|
Norsk Hydro ASA
OTC:NHYDY
|
NO |
|
W
|
WF International Ltd
NASDAQ:WXM
|
CN |
|
I
|
Ichiken Co Ltd
TSE:1847
|
JP |
|
A
|
Aboitiz Power Corp
XPHS:AP
|
PH |
|
Rave Restaurant Group Inc
NASDAQ:RAVE
|
US |
|
Xtra Gold Resources Corp
TSX:XTG
|
BS |
|
K
|
Kroger Co
DUS:KOG
|
US |
|
S
|
Swire Pacific Ltd
HKEX:87
|
HK |
|
M
|
Markel Corp
LSE:0JYM
|
US |
|
S
|
Syntholene Energy Corp
OTC:SYNTF
|
CA |
|
A
|
Ad Pepper Media International NV
DUS:APM
|
DE |
|
Nanofilm Technologies International Ltd
SGX:MZH
|
SG |
|
Paymentus Holdings Inc
NYSE:PAY
|
US |
|
Oriole Resources PLC
LSE:ORR
|
UK |
Bankruptcy Probability
Ryvu Therapeutics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ryvu Therapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
R
|
Ryvu Therapeutics SA
WSE:RVU
|
430m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
256.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
163.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
422.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
44.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
50B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
63.9T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
46B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
44.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Illumina Inc
NASDAQ:ILMN
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mettler-toledo International Inc
NYSE:MTD
|
36.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ryvu Therapeutics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ryvu Therapeutics SA has total debt of 83m PLN. This includes both short-term (0 PLN) and long-term (83m PLN) debt.
You can find a full breakdown on its Balance Sheet.